Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899028 · ClinicalTrials.gov registry record
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 689
- Enrollment target
NCT00899028 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 689 participants.
The verdict
NCT00899028 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 689 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tissue, blood, sputum, and urine from patients with lung cancer and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at biomarkers for lung cancer using tissue samples from patients with lung cancer and from healthy participants.
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- GENETIC protein expression analysis
- GENETIC fluorescence in situ hybridization
- GENETIC comparative genomic hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 689 participants |
| Start Date | 2001-05 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00899028
The ClinicalTrials.gov registry entry for NCT00899028 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 689 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00899028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00899028 about?
NCT00899028 is a clinical study titled "Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants". RATIONALE: Studying samples of tissue, blood, sputum, and urine from patients with lung cancer and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at biomarkers...
What is the current status of trial NCT00899028?
This trial is currently completed. The enrollment target is 689 participants. The study started on 2001-05. Estimated completion is 2016-08.
What interventions are being tested in trial NCT00899028?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), protein expression analysis (GENETIC), fluorescence in situ hybridization (GENETIC), comparative genomic hybridization (GENETIC).
Who is sponsoring clinical trial NCT00899028?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.